Predicting Recurrence in HR+/HER2- Early Breast Cancer

Clinical trial NCT07484763 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07484763
Sponsor: Shengjing Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Breast Cancer, HR+/HER2- Early-Stage

Start date: 2026-04-01
Primary completion: 2026-07-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.